Valion Bio, Inc.: issues press release on Velocity Bioworks developments

What happened

• Valion Bio, Inc. announced on Oct 26, 2026 that it issued a press release regarding recent developments concerning its contract development and manufacturing organization, Velocity Bioworks.
• The press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference.

Key details

• Filing type: Current Report on Form 8-K.
• Reported item: Item 8.01 (Other events).
• Exhibit: Exhibit 99.1 (press release dated Oct 26, 2026).
• The filing includes standard forward-looking statements language referencing terms such as “anticipates,” “expects,” “estimates,” “believes” and “will.”

Why it may matter

• Item 8.01 covers other events; here the company reported that it issued and filed a press release about developments at its contract development and manufacturing organization, Velocity Bioworks.
• This filing does not show why the insider traded or why the company acted.